Another implication of the present study is that it might be important to completely inhibit SCD activity in human cancer cells in order to achieve sufficient tumor growth inhibition in vivo, whereas a partial SCD inhibitor might have limited therapeutic efficacy. This evidence concerns the gene SCD and neoplasm.